| [1] |
Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(1): 9-29.
|
| [2] |
Chen WQ, Zhang SR, Zhang SW, et al. Report of cancer incidence and mortality in China, 2012 [J]. China Cancer, 2016, 25(1): 1-8.
|
| [3] |
Benedix F, Kube R, Meyer F, et al. Comparison of 17, 641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival [J]. Dis Colon Rectum, 2010, 53(1): 57-64.
|
| [4] |
Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location [J]. Ann Intern Med, 1990, 113(10): 779-788.
|
| [5] |
Cheng L, Eng C, Nieman LZ, et al. Trends in colo-rectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005 [J]. Am J Clin Oncol, 2011, 34(6): 573-580.
|
| [6] |
Boise MK, Johansen JS, Dehlendorff C, et al. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer [J]. Annals of Oncology, 2013, 24(10): 2554-2559.
|
| [7] |
Carethers JM. One colon lumen but two organs [J]. Gastroenterology, 2011, 141(2): 411-442.
|
| [8] |
Wu X, Chen VW, Martin J, et al. Sub-site-specific colorectal cancer incidence rates and stage distributions among Asians an d Pacific Islanders in the United States, 1995 to 1999 [J]. Cancer Epidemioly Biomarkers Prev, 2004, 13(7): 1215-1222.
|
| [9] |
Chin CC, Wang JY, Yeh CY, et al. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases Ⅲ colon cancer [J]. Int J Colorectal Dis, 2009, 24(11): 1297-1302.
|
| [10] |
Albuquerque C, Bakker ER, van Veelen W, et al. Colorectal cancers choosing sides [J]. Biochim Biophys Acta, 2011, 1816(2): 219-231.
|
| [11] |
Rebecca LS, Elizabeth MW, Ahmedin J. Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 [J]. American Association for Cancer Research, 2012, 21(3): 411-416.
|
| [12] |
Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease [J]. Cancer, 2015, 121(6): 830-835.
|
| [13] |
Weiss JM, Pfau PR, OʹConnor ES, et al. Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data [J]. J Clin Oncol: official journal of the American Society of Clinical Oncology, 2011, 29(33): 4401-4409.
|
| [14] |
Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right-versus left-sided colon cancers? [J]. Ann Surg Oncol, 2008, 15(9): 2388-2394.
|
| [15] |
Snaebjornsson P, Coupe VM, Jonasson L, et al. Colon cancer in Iceland--a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age [J]. Int J Cancer, 2010, 127(11): 2645-2653.
|
| [16] |
Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities [J]. Clin Biochem Rev, 2010, 31(2): 31-38.
|
| [17] |
Nosho K, Irahara N, Shima K, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample [J]. PloS One, 2008, 3(11): e3698.
|
| [18] |
Roth AD, Delorenzi M, Tejpar S, et al. Integrated analysis of molecular and clinical prognostic factors in stageⅡ/Ⅲ colon cancer [J]. J Natl Cancer Inst, 2012, 104(21): 1635-1646.
|
| [19] |
Bae JM, Kim JH, Cho NY, et al. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumor location [J]. Br J Cancer, 2013, 109(4): 1004-1012.
|
| [20] |
Barault L, Charon-Barra C, Jooste V, et al. Hypermethylatorpheno type in sporadic colon cancer: study on a population-based series of 582 cases [J]. Cancer Res, 2008, 68(20): 8541-8546.
|
| [21] |
Weisenberger DJ, Siegmund KD, Campan M, et al. CpG islandmethylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer [J]. Nat Genet, 2006, 38(7): 787-793.
|
| [22] |
Russo A, Bazan V, Iacopetta B, et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment [J]. J Clin Oncol, 2005, 23(30): 7518-7528.
|
| [23] |
Brule SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a pregnostic factor and a predictor of benefit from cetuximab in NCIC CO.17 [J]. Eur J Cancer, 2015, 51(11): 1405-1414.
|
| [24] |
von Einem JC, Heinemann V, von Weikersthal LF, et al. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS cod on 1213 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial [J]. J Cancer Res Clin Oncol, 2014, 140(9): 1607-1614.
|
| [25] |
Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution [J]. Surg Today, 2014, 44(9): 1685-1691.
|
| [26] |
Gao P, Song YX, Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumor site? Results from two independent databases [J]. Histopathology, 2013, 63(5): 603-615.
|